Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer
2022 · BMC Cancer · 33 citations
https://doi.org/10.1186/s12885-022-10122-4
Z
Zewei Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
585
Citations
15
h-index
20
i10-index
Zewei Lin is an academic researcher from Harbin Institute of Technology. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Congenital Heart Disease Studies & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 15, co-authored 60 publications.
ORCID: 0000-0003-1557-1503Papers by this author
worksEffect of Music Therapy on the Chronic Pain and Midterm Quality of Life of Patients after Mechanical Valve Replacement
2020 · Annals of Thoracic and Cardiovascular Surgery · 21 citations
https://doi.org/10.5761/atcs.oa.20-00022
The effect of music therapy on chronic pain, quality of life and quality of sleep in adolescents after transthoracic occlusion of ventricular septal defect
2021 · The Heart Surgery Forum · 10 citations
https://doi.org/10.1532/hsf.3513
Short-term follow-up of single-port thoracoscopic rib fracture reduction and internal fixation for the treatment of multiple rib fractures
2024 · Archives of Orthopaedic and Trauma Surgery · 2 citations
https://doi.org/10.1007/s00402-024-05647-1
The Influence Mechanism Between Structural Monetary Policy & Financing Constraints of SMEs
2022 · SSRN Electronic Journal · 0 citations
https://doi.org/10.2139/ssrn.4095323
Additional file 4 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21275750
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat